Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DAHANCA 33: Functional Image Guided Dose-escalated Radiotherapy to Patients With Hypoxic Squamous Cell Carcinoma of the Head and Neck

NCT02976051 is registered in ClinicalTrials.gov with Danish Head and Neck Cancer Group as lead sponsor.

NCT NCT02976051
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02976051 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DAHANCA 33: Functional Image Guided Dose-escalated Radiotherapy to Patients With Hypoxic Squamous Cell Carcinoma of the Head and Neck
Lead sponsor
Danish Head and Neck Cancer Group
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 2017
Completion date
December 31, 2022
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypoxic radioresistance, locally advanced head and neck cancer, radiotherapy